Latest Breaking News On - Asamts13 - Page 1 : comparemela.com

Judicious use of caplacizumab (Cabilivi) can reduce the risk of severe bleeding and help manage costs associated with the therapy in patients living with thrombotic thrombocytopenic purpura (TTP).

Caplacizumab cabiliviRavi sarodeUniversity of texas southwestern medical centerTexas southwestern medical center